{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:36:32Z","timestamp":1787747792826,"version":"build-2784847793"},"reference-count":19,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Euglycemic ketoacidosis is metabolic acidosis with elevated ketone bodies despite normal or mildly elevated glucose levels and has rarely been reported in nonobese individuals without diabetes using tirzepatide. A 23-year-old Japanese woman without obesity presented with a 4-day history of nausea, vomiting, and diarrhea after the second self-administered dose of tirzepatide (2.5\u2005mg) obtained through an aesthetic clinic without ongoing medical supervision. She had no history of diabetes, alcohol consumption, or carbohydrate restriction. Laboratory results showed high anion gap metabolic acidosis (anion gap: 25.9\u2005mmol\/L) [normal reference range (ref): 8-16\u2005mmol\/L], elevated serum \u03b2-hydroxybutyrate (5.5\u2005mmol\/L) (ref: &amp;lt;0.07\u2005mmol\/L) and acetoacetate (1.4\u2005mmol\/L) (ref: &amp;lt;0.01-0.07\u2005mmol\/L), with concomitant metabolic alkalosis compatible with vomiting and mild hyperglycemia (196\u2005mg\/dL [SI:10.9\u2005mmol\/L]) (ref: 70-100\u2005mg\/dL [SI: 3.9-5.6\u2005mmol\/L]). No definitive infectious source was identified on evaluation, and euglycemic ketoacidosis was diagnosed. She received intravenous fluids containing glucose, electrolytes, and continuous insulin infusion, which rapidly corrected the acidosis. Her symptoms resolved within several days, and follow-up evaluation confirmed normal glucose tolerance. This case adds to the limited clinical evidence of tirzepatide-associated euglycemic ketoacidosis in a non-obese individual without diabetes. Caution is warranted regarding the off-label use of tirzepatide for aesthetic weight reduction.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag054","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:38:56Z","timestamp":1771418336000},"source":"Crossref","is-referenced-by-count":2,"title":["Ketoacidosis associated with tirzepatide use in a nonobese individual without diabetes"],"prefix":"10.1210","volume":"4","author":[{"given":"Ryosuke","family":"Kemmotsu","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Osaka International Medical and Science Center (Osaka Keisatsu Hospital) , 2-6-40 Karasugatsuji Tennoji-ku, Osaka 543-0035, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Okita","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Osaka International Medical and Science Center (Osaka Keisatsu Hospital) , 2-6-40 Karasugatsuji Tennoji-ku, Osaka 543-0035, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Osaka International Medical and Science Center (Osaka Keisatsu Hospital) , 2-6-40 Karasugatsuji Tennoji-ku, Osaka 543-0035, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Inui","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Osaka International Medical and Science Center (Osaka Keisatsu Hospital) , 2-6-40 Karasugatsuji Tennoji-ku, Osaka 543-0035, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tabuchi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Osaka International Medical and Science Center (Osaka Keisatsu Hospital) , 2-6-40 Karasugatsuji Tennoji-ku, Osaka 543-0035, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-8834","authenticated-orcid":false,"given":"Tetsuyuki","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Osaka International Medical and Science Center (Osaka Keisatsu Hospital) , 2-6-40 Karasugatsuji Tennoji-ku, Osaka 543-0035, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"2026041106555719700_luag054-B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2019.03.014","article-title":"Euglycemic diabetic ketoacidosis","volume":"63","author":"Barski","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"5","key":"2026041106555719700_luag054-B2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/metabo14050264","article-title":"Ketoacidosis and SGLT2 inhibitors: a narrative review","volume":"14","author":"Morace","year":"2024","journal-title":"Metabolites"},{"issue":"6","key":"2026041106555719700_luag054-B3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Frias","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"2026041106555719700_luag054-B4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"2026041106555719700_luag054-B5","first-page":"415","article-title":"Tirzepatide for the treatment of obesity: clinical evidence and mechanistic insights","volume":"19","author":"Lau","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"2026041106555719700_luag054-B6","doi-asserted-by":"crossref","first-page":"1453825","DOI":"10.3389\/fphar.2024.1453825","article-title":"Tirzepatide's innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health","volume":"15","author":"Yang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"6","key":"2026041106555719700_luag054-B7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(22)00085-7","article-title":"Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial","volume":"10","author":"Heise","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026041106555719700_luag054-B8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metab"},{"issue":"4","key":"2026041106555719700_luag054-B9","first-page":"004357","article-title":"Tirzepatide-induced ketoacidosis in non-diabetic patients","volume":"11","author":"Iqbal","year":"2024","journal-title":"Eur J Case Rep Intern Med"},{"key":"2026041106555719700_luag054-B10","doi-asserted-by":"crossref","first-page":"e946133","DOI":"10.12659\/AJCR.946133","article-title":"Exploring hypoglycemic ketoacidosis in nondiabetic patients on tirzepatide: is starvation the culprit?","volume":"25","author":"Bitar","year":"2024","journal-title":"Am J Case Rep"},{"issue":"3","key":"2026041106555719700_luag054-B11","article-title":"Euglycemic ketoacidosis following coadministration of an SGLT2 inhibitor and tirzepatide","volume":"3","author":"Louwagie","year":"2025","journal-title":"JCEM Case Rep"},{"issue":"12","key":"2026041106555719700_luag054-B12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJM197003192821209","article-title":"Starvation in man","volume":"282","author":"Cahill","year":"1970","journal-title":"N Engl J Med"},{"issue":"4","key":"2026041106555719700_luag054-B13","doi-asserted-by":"crossref","first-page":"E1103","DOI":"10.1152\/ajpendo.00613.2006","article-title":"Effects of fasting on insulin action and glucose kinetics in lean and obese men and women","volume":"293","author":"Bergman","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"2026041106555719700_luag054-B14","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/oby.2008.678","article-title":"Effects of insulin on ketogenesis following fasting in lean and obese men","volume":"17","author":"Soeters","year":"2009","journal-title":"Obesity"},{"issue":"5","key":"2026041106555719700_luag054-B15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2025.03.011","article-title":"Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation","volume":"37","author":"Ravussin","year":"2025","journal-title":"Cell Metab"},{"issue":"7","key":"2026041106555719700_luag054-B16","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","article-title":"Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor","volume":"36","author":"Regmi","year":"2024","journal-title":"Cell Metab"},{"issue":"4","key":"2026041106555719700_luag054-B17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.ijo.0803050","article-title":"Body image and weight control in young adults: international comparisons in university students from 22 countries","volume":"30","author":"Wardle","year":"2006","journal-title":"Int J Obes"},{"issue":"4","key":"2026041106555719700_luag054-B18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40519-014-0130-7","article-title":"Eating behavior and perception of body shape in Japanese university students","volume":"19","author":"Ohara","year":"2014","journal-title":"Eat Weight Disord"},{"issue":"5","key":"2026041106555719700_luag054-B19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1539\/joh.49.376","article-title":"Degree of agreement between weight perception and body mass index of Japanese workers: MY health up study","volume":"49","author":"Inoue","year":"2007","journal-title":"J Occup Health"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/4\/luag054\/67989390\/luag054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/4\/luag054\/67989390\/luag054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:56:06Z","timestamp":1775904966000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag054\/8643948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,19]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag054","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,19]]},"article-number":"luag054"}}